It really depends on duration and steadiness, not intensity, to determine which medication is best for you
That data doubles down on what has proven to be a uniquely lucrative segment for the company, which announced in its Q4 earnings call that it is the GLP-1 market leader with a volume market share of 63%
Common criteria include failed trials of oral diabetes medications, documented BMI thresholds (often 30+), and baseline metabolic or cardiometabolic risk factors
The publisher of this article is not responsible for typographical errors, manufacturer changes to the product after publication, or individual consumer outcomes
The brand is intended to reflect who WeightWatchers is today: integrated, intelligent, evidence-based, and grounded in real-life human care
These medications mimic the role of the naturally occurring hormone that regulates appetite and glucose metabolism